Fukumi Yoshikawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Insulin-reducing effect of adding imeglimin to ongoing dipeptidyl peptidase-4 inhibitor therapy with multiple daily insulin injections (INSPIRE study).
Journal: Journal of diabetes investigation
Published: March 02, 2026
Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 15, 2026
Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes: A Retrospective Observational Multicenter Study (ORIGAMI Study).
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 04, 2025
Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: September 28, 2024
Glycemic variability and quality of life outcomes after changing to hybrid closed-loop system in Japanese individuals with type 1 diabetes using a conventional predictive low-glucose suspended insulin pump system.
Journal: Diabetology international
Published: May 29, 2024
Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 30, 2023
SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes.
Journal: Diabetology & metabolic syndrome
Published: December 08, 2022
Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.
Journal: Diabetology international
Published: March 17, 2021
Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.
Journal: Diabetology international
Published: January 02, 2021
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: October 29, 2020
Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.
Journal: Diabetes research and clinical practice
Published: March 18, 2020
Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice.
Journal: American journal of physiology. Endocrinology and metabolism
Published: July 11, 2018
Last Updated: 09/26/2026